ask="2.70"
ask_size="100"
average_daily_volume="142105"
bid="2.38"
bid_size="3000"
book_value="1.73"
change="-0.03"
change_from_200_day_moving_average="-0.71"
change_from_50_day_moving_average="0.02"
change_from_52_week_high="-11.40"
change_From_52_week_low="0.77"
change_in_percent="-1.14%"
close="2.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.31"
ebitda="-24.04M"
eps_estimate_current_year="-5.20"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-5.20"
ex_dividend_date="N/A"
float_shares="3535000"
high="2.79"
high_52_weeks="14.00"
last_trade_date="3/10/2017"
last_trade_price="2.60"
last_trade_size="208"
last_trade_time="4:02pm"
low="2.50"
low_52_weeks="1.83"
market_capitalization="9.24M"
moving_average_200_day="3.31"
moving_average_50_day="2.58"
name="ImmunoCellular Therapeutics
Lt"
notes="N/A"
one_year_target_price="5.00"
open="2.50"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-21.54%"
percent_change_from_50_day_moving_average="+0.85%"
percent_change_from_52_week_high="-81.43%"
percent_change_from_52_week_low="+42.08%"
previous_close="2.63"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.52"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="3552000"
short_ratio="1.75"
stock_exchange="ASE"
symbol="IMUC"
volume="94718"
weeks_range_52="1.83 - 14.00"
